Evidence map›Paper›PMID 38696263›Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2024

The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact.

Raj Kalaria, Gladys Maestre, Simin Mahinrad, Daisy M Acosta, Rufus Olusola Akinyemi, Suvarna Alladi, Ricardo F Allegri, Faheem Arshad, David Oluwasayo Babalola, Olusegun Baiyewu and 72 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. The Cog-Aging: a 15-year cohort study of cognition in Brazilian older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  8. Article
  9. Risk factors and population attributable fraction for dementia in American Indians: The Strong Heart Study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Longitudinal Evaluation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Observational
  15. Article
  16. Review
  17. Bibliometric analysis of Alzheimer's and dementia research in Latin America.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  18. Article
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

82 authors.

Raj KalariaTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Gladys MaestreDepartments of Neuroscience and Human Genetics, University of Texas Rio Grande Valley, One W. University Blvd, Brownsville, Texas, USA.
Simin MahinradDivision of Medical and Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.ORCID 0000-0002-5927-7130
Daisy M AcostaUniversidad Nacional Pedro Henriquez Urena (UNPHU), Santo Domingo, Dominican Republic.
Rufus Olusola AkinyemiNeuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
Suvarna AlladiDepartment of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Ricardo F AllegriFleni Neurological Institute, Buenos Aires, Argentina.
Faheem ArshadDepartment of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
David Oluwasayo BabalolaCollege of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
Olusegun BaiyewuDepartment of Psychiatry, University of Ibadan, Ibadan, Oyo, Nigeria.
Thomas H BakUniversity of Edinburgh, Edinburgh, UK.
Tarek BellajTunis University, Tunis, Tunisia.
David K Brodie-MendsKorle-Bu Teaching Hospital, Accra, Ghana.
Maria C CarrilloDivision of Medical and Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.
Kaputu-Kalala-Malu CelestinDepartment of Neurology, Centre Neuropsychopathologique (CNPP), Kinshasa University Teaching Hospital, University of Kinshasa, Kinshasa, Republic Democratic of the Congo.
Albertino DamascenoFaculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Ranil Karunamuni de SilvaInterdisciplinary Centre for Innovation in Biotechnology and Neuroscience, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Rohan de SilvaReta Lila Weston Institute and Department of Clinical, Movement Neuroscience, UCL Queen Square Institute of Neurology, London, UK.
Mamuka DjibutiPartnership for Research and Action for Health (PRAH), Tbilisi, Georgia.
Anna Jane DreyerUniversity of Cambridge, The Old Schools, Cambridge, UK.
Ratnavalli EllajosyulaCognitive Neurology Clinic, Manipal Hospital, and Annasawmy Mudaliar Hospital, Bengaluru, Karnataka, India.
Temitope H FarombiTony Anenih Geriatric Center, University College Hospital, Ibadan, Oyo, Nigeria.
Robert P FriedlandUniversity of Louisville, Louisville, Kentucky, USA.
Noe GarzaDepartment of Neuroscience and Human Genetics, University of Texas Rio Grande Valley, Harlingen, Texas, USA.
Antoine GbessemehlanInserm U1094, IRD U270, University of Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.
Eliza Eleni-Zacharoula GeorgiouDepartment of Psychiatry, Patras University General Hospital, Faculty of Medicine, School of Health Sciences, University of Patras, Patras, Greece.
Ishtar GoviaCaribbean Institute for Health Research, The University of the West Indies, Jamaica, West Indies, Jamaica.
Lea T GrinbergDepartment of Neurology and Pathology, University of California San Francisco, San Francisco, California, USA.
Maëlenn GuerchetInserm U1094, IRD U270, University of Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.
Seid Ali GugssaDepartment of Neurology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Joy Louise Gumikiriza-OnoriaDepartment of Psychiatry, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Eef HogervorstLoughborough University, Loughborough, UK.
Michael HornbergerNorwich Medical School, University of East Anglia, Norwich, UK.
Agustin IbanezLatin American Institute for Brain Health (BrainLat), Universidad Adolfo Ibanez, Peñalolén, Santiago, Chile.
Masafumi IharaDepartment of Neurology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Thomas Gregor IssacCentre for Brain Research, Indian Institute of Science (IISc), Bengaluru, Karnataka, India.
Linus JönssonDepartment of Neurobiology, Care Science and Society, section for Neurogeriatrics, Karolinska Institute, Solnavägen, Solna, Sweden.
Wambui M KaranjaGlobal Brain Health Institute (GBHI), Trinity College Dublin, Lloyd Building Trinity College Dublin, Dublin, Ireland.
Joseph H LeeSergievsky Center, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Departments of Neurology and Epidemiology, Columbia University, New York, New York, USA.
Iracema LeroiGlobal Brain Health Institute (GBHI), Trinity College Dublin, Lloyd Building Trinity College Dublin, Dublin, Ireland.
Gill LivingstonUniversity College London, London, UK.
Facundo Francisco ManesInstitute of Cognitive and Translational Neuroscience (INCYT), INECO Foundation, Favaloro University, Buenos Aires, Argentina.
Lingani Mbakile-MahlanzaGlobal Brain Health Institute (GBHI), University California San Francisco (UCSF), San Francisco, California, USA.
Bruce L MillerDepartment of Neurology, Memory and Aging Center, University of California San Francisco Weill Institute for Neurosciences, San Francisco, California, USA.
Christine Wayua MusyimiAfrica Mental Health Research and Training Foundation, Nairobi, Kenya.
Victoria N MutisoAfrica Mental Health Research and Training Foundation, Nairobi, Kenya.
Noeline NakasujjaMakerere University College of Health Sciences, Kampala, Uganda.
David M NdeteiAfrica Mental Health Research and Training Foundation, Nairobi, Kenya.
Sam NightingaleNeuroscience Institute, University of Cape Town, Cape Town, South Africa.
Gabriela NovotniUniversity Clinic of Neurology, Medical Faculty University Ss Cyril and Methodius Institute for Alzheimer's Disease and Neuroscience, Skopje, North Macedonia.
Primrose NyamayaroGlobal Brain Health Institute (GBHI), Trinity College Dublin, Lloyd Building Trinity College Dublin, Dublin, Ireland.
Solomon NyameKintampo Health Research Centre, Ghana Health Service, Hospital Road, Near Kintampo-north Municipal Hospital, Kintampo, Ghana.
Julius A Ogeng'oUniversity of Nairobi, Nairobi, Kenya.
Adesola OgunniyiCollege of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
Maira Okada de OliveiraGlobal Brain Health Institute (GBHI), University California San Francisco (UCSF), San Francisco, California, USA.
Njideka U OkubadejoNeurology Unit, Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Yaba, Lagos, Nigeria.
Martin OrrellInstitute of Mental Health, University of Nottingham, Nottingham, UK.
Stella-Maria PaddickNewcastle University, Newcastle upon Tyne, UK.
Margaret A Pericak-VanceJohn P Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Coral Gables, Florida, USA.
Zvezdan PirtosekFaculty of Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Felix Claude Victor PotocnikOld Age Psychiatry Unit, Depth Psychiatry, Stellenbosch University, Western Cape, Stellenbosch Central, Stellenbosch, South Africa.
Rema RamanAlzheimer's Therapeutic Research Institute, University of Southern California, Los Angeles, California, USA.
Mie RizigDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London, UK.
Mónica RosselliDepartment of Psychology, Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, Florida, USA.
Marufjon SalokhiddinovTashkent Medical Academy, Tashkent, Uzbekistan.
Claudia L SatizabalGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, Texas, USA.
Diego Sepulveda-FallaMolecular Neuropathology of Alzheimer's Disease, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Sudha SeshadriGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases and South Texas ADRC, UT Health San Antonio, San Antonio, Texas, USA.
Claire E SextonDivision of Medical and Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.
Ingmar SkoogInstitute of Neuroscience and Fysiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Peter H St George-HyslopTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA.
Claudia Kimie SuemotoDivision of Geriatrics, University of Sao Paulo Medical School, R. da Reitoria, R. Cidade Universitária, São Paulo, Sao Paulo, Brazil.
Prekshy ThapaGlobal Brain Health Institute (GBHI), Trinity College Dublin, Lloyd Building Trinity College Dublin, Dublin, Ireland.
Chinedu Theresa Udeh-MomohGlobal Brain Health Institute (GBHI), University California San Francisco (UCSF), San Francisco, California, USA.
Victor ValcourMemory and Aging Center, Department of Neurology, University of California, San Francisco, California, USA.
Jeffery M VanceJohn P Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Coral Gables, Florida, USA.
Mathew VargheseSt. John's Medical College, Sarjapur - Marathahalli Rd, beside Bank Of Baroda, John Nagar, Koramangala, Bengaluru, Karnataka, India.
Jaime H VeraDepartment of Global Health and Infection, Brighton and Sussex Medical School, Brighton, UK.
Richard W WalkerPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden.
Yared Z ZewdeDepartment of Neurology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Ozama IsmailDivision of Medical and Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.

Funding

The Health & Aging Brain Study - Health Disparities (HABS-HD)U19AG078109 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI LEIGH A JOHNSON · 2022 to 2026
$181.1M
The Long Life Family StudyU19AG063893 · NIA · WASHINGTON UNIVERSITY · PI Michael A. Province · 2019 to 2026
$125.4M
Project 3: Biomarkers for DS Clinical TrialsU19AG068054 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, JOSEPH HYUNGWOO · 2020 to 2025
$103.7M
Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Physical activity, physical function, and frailty in relation to cognitive impairment and AD/ADRD biomarkers in DPPOSU19AG078558 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jose Alejandro Luchsinger, DAVID M NATHAN · 2022 to 2026
$82.5M
TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP)U19AG074865 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GOLDIE S. BYRD, William S Bush · 2022 to 2026
$55.3M
The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD)R01AG070883 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI AMY J. KIND · 2021 to 2026
$42.1M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Katherine P Rankin · 2019 to 2026
$36.9M
Biomarkers of Alzheimer's Disease in Adults with Down SyndromeU01AG051412 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LOTT, IRA T., SCHUPF, NICOLE · 2015 to 2019
$26.3M
The Origins of Alzheimer Disease in African AmericansR01AG072547 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Rufus Olusola Akinyemi, GOLDIE S. BYRD · 2022 to 2026
$26.1M
Social Determinants of Health, Race/Ethnicity, and White Matter HyperintensitiesP30AG066506 · NIA · UNIVERSITY OF FLORIDA · PI Ranjan Duara, DAVID LOEWENSTEIN · 2020 to 2026
$25.6M
Alzheimer Drug Discovery Foundation 201809-2016862Alzheimer Drug Discovery Foundation ADSF-21-831376-CAlzheimer Drug Discovery Foundation ADSF-21-831377-CAlzheimer Drug Discovery Foundation ADSF-21-831381-CAlzheimer's Association, USAAlzheimer's Drug Discovery Foundation (ADDF)Appel à Projet des Equipes Émergentes et Labellisées scheme (APREL)AXA Research FundBluefield Project, the Olav Thon Foundation, the Erling-Persson Family Foundation, Stiftelsen för Gamla Tjänarinnor, Hjärnfonden, SwedenCanadian Institute of Health ResearchChinese Neuroscience Society, ChinaEuropean Union Joint Programme - Neurodegenerative Disease Research JPND2021-00694European Union's Horizon Europe 101053962FIC NIH HHS D43 TW011532FIC NIH HHS R25 TW011214French National Research Agency ANR-09-MNPS-009-01Global Brain Health Institute (GBHI)GOK: Government of KarnatakaHealth Professionals Education Partnership Initiative EthiopiaICMR: Indian Council for Medical ResearchInternational Society for NeurochemistryLSIPL: M/s Lowes Services India Private LimitedMarie Skłodowska-CurieMichael J. Fox Foundation for Parkinson's Research, USAMinistry of Primary Industries, Sri Lanka SP/CIN/2016/02)Multi partner Consortium for Dementia Research in Latino America-Dominican Republic (LATAM-FINGERS) R01AG072547Multi partner Consortium for Dementia Research in Latino America-Dominican Republic (LATAM-FINGERS) U01HG010273Multi partner Consortium for Dementia Research in Latino America-Dominican Republic (LATAM-FINGERS) U19AG074865National Council for Scientific and Technological DevelopmentNational Institute for Health and Care Research, United KingdomNational Institute for Health and Care Research University College London Hospitals Biomedical Research CentreNational Institute of Aging (NIA) 1R01AG068472-01National Institute of Aging (NIA) P30AG066506National Institute of Aging (NIA) R01AG080468-01National Institutes of Health (NIH) 1P30AG066546-01A1National Institutes of Health (NIH) 1R13AG066391-01National Institutes of Health (NIH) DP1AG069870National Institutes of Health (NIH) SG-21-814756National Research Foundation (NRF)NCATS NIH HHS UL1 TR001873NHGRI NIH HHS U01 HG010273NIA NIH HHS DP1 AG069870NIA NIH HHS K24 AG053435NIA NIH HHS P01 AG019724NIA NIH HHS P30 AG059305NIA NIH HHS P30 AG062422NIA NIH HHS P30 AG066506NIA NIH HHS P30 AG066546NIA NIH HHS R01 AG052496NIA NIH HHS R01 AG054076NIA NIH HHS R01 AG057234NIA NIH HHS R01 AG058464NIA NIH HHS R01 AG058918NIA NIH HHS R01 AG059421NIA NIH HHS R01 AG060477NIA NIH HHS R01 AG062562NIA NIH HHS R01 AG062588NIA NIH HHS R01 AG066524NIA NIH HHS R01 AG068472NIA NIH HHS R01 AG070864NIA NIH HHS R01 AG070883NIA NIH HHS R01 AG072547NIA NIH HHS R01 AG075775NIA NIH HHS R01 AG080468NIA NIH HHS R13 AG066391NIA NIH HHS R21 AG069252NIA NIH HHS R35 AG072362NIA NIH HHS R56 AG061837NIA NIH HHS R56 AG074467NIA NIH HHS RF1 AG059018NIA NIH HHS RF1 AG059421NIA NIH HHS RF1 AG061872NIA NIH HHS RF1 AG063507NIA NIH HHS U01 AG051412NIA NIH HHS U01 AG052409NIA NIH HHS U01 AG058589NIA NIH HHS U19 AG063893NIA NIH HHS U19 AG068054NIA NIH HHS U19 AG074865NIA NIH HHS U19 AG078109NIA NIH HHS U19 AG078558NICHD NIH HHS P01 HD035897NIH and the Fogarty International Center [FIC] R01 AG21051NINDS NIH HHS R01 NS050915NINDS NIH HHS UF1 NS125513NINDS NIH HHS UH3 NS100605Pilot Award for Global Brain Health Leaders GBHI ALZ UK-21-724359Rainwater Charitable Foundation - The Bluefield project to cure FTD, and Global Brain Health InstituteRBM: Rotary Bangalore MidtownSwedish Research Council 2019-02397Swedish Research Council 2022-01018Swedish State Support for Clinical Research ALFGBG-71320UK Dementia Research Institute at UCL UKDRI-1003UK National Health Service, Newcastle University,UK Royal Society/African Academy of Sciences FCG/R1/201034UK Royal Society/African Academy of Sciences FLR/R1/191813University of Sri Jayewardenepura, Sri Lanka ASP/06/RE/2010/07University of Sri Jayewardenepura, Sri Lanka ASP/06/RE/2012/18University of Sri Jayewardenepura, Sri Lanka ASP/06/RE/2013/28University of Sri Jayewardenepura (USJ), Sri Lanka WCUP/Ph.D./19/2013University of Sri Jayewardenepura (USJ), Sri Lanka WCUP/Ph.D./19B 2013University of Wisconsin, Madison 1R01AG070883Wellcome TrustWellcome Trust, UK
6 · The paper itself

Abstract

Two of every three persons living with dementia reside in low- and middle-income countries (LMICs). The projected increase in global dementia rates is expected to affect LMICs disproportionately. However, the majority of global dementia care costs occur in high-income countries (HICs), with dementia research predominantly focusing on HICs. This imbalance necessitates LMIC-focused research to ensure that characterization of dementia accurately reflects the involvement and specificities of diverse populations. Development of effective preventive, diagnostic, and therapeutic approaches for dementia in LMICs requires targeted, personalized, and harmonized efforts. Our article represents timely discussions at the 2022 Symposium on Dementia and Brain Aging in LMICs that identified the foremost opportunities to advance dementia research, differential diagnosis, use of neuropsychometric tools, awareness, and treatment options. We highlight key topics discussed at the meeting and provide future recommendations to foster a more equitable landscape for dementia prevention, diagnosis, care, policy, and management in LMICs. HIGHLIGHTS: Two-thirds of persons with dementia live in LMICs, yet research and costs are skewed toward HICs. LMICs expect dementia prevalence to more than double, accompanied by socioeconomic disparities. The 2022 Symposium on Dementia in LMICs addressed advances in research, diagnosis, prevention, and policy. The Nairobi Declaration urges global action to enhance dementia outcomes in LMICs.

Indexed as

AgingDementiaDeveloping CountriesBiomedical ResearchBrainCongresses as TopicHumansAlzheimer's diseasedementiadiversityhigh‐income countrieslow‐ and middle‐income countriesrisk factorsvascular dementia

Identifiers

PMID38696263
PMCPMC11180946

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.